Last update 21 Nov 2024
PZH-2111
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism FGFR2 antagonists(Fibroblast growth factor receptor 2 antagonists), FGFR3 antagonists(Fibroblast growth factor receptor 3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with PZH-2111评价 PZH2111 片治疗 FGFR 基因异常晚期实体瘤患者及 FGFR2 基因融合突变晚期肝内胆管细胞癌患者的安全性、有效性及药代动力学特征的开放、多中心、I/II 期临床研究
[Translation] An open, multicenter, phase I/II clinical study to evaluate the safety, efficacy, and pharmacokinetic characteristics of PZH2111 tablets in the treatment of patients with advanced solid tumors with FGFR gene abnormalities and patients with advanced intrahepatic cholangiocarcinoma with FGFR2 gene fusion mutations
100 Clinical Results associated with PZH-2111
Login to view more data
100 Translational Medicine associated with PZH-2111
Login to view more data
100 Patents (Medical) associated with PZH-2111
Login to view more data
100 Deals associated with PZH-2111
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 27 Dec 2021 | |
| Intrahepatic Cholangiocarcinoma | Phase 2 | CN | 27 Dec 2021 | |
| Bile Duct Neoplasms | Preclinical | CN | 30 Apr 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free